Kyogoku unyu shoji
9073
BlueMeme
4069
Estore
4304
Visumo
303A
D. Western Therapeutics Institute
4576
(Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | 26.66%2.23B | 235.20%868M | 2,747.37%2.71B | -76.48%669M | 50.66%919M | 147.01%1.76B | -267.62%-642M | -97.56%95M | 77.20%2.84B | -21.79%610M |
Net profit before non-cash adjustment | -164.29%-333M | 755.29%3.28B | -17,500.00%-176M | 113.47%97M | -43.99%354M | -157.14%-126M | -468.38%-501M | 99.75%-1M | 23.40%-720M | 1,720.51%632M |
Total adjustment of non-cash items | 1,082.35%201M | -223.16%-2.54B | 98.72%2.96B | -40.45%53M | -16.01%829M | 103.95%17M | 144.37%2.06B | -67.78%1.49B | -95.44%89M | -34.02%987M |
-Depreciation and amortization | 0.94%752M | 4.53%738M | 0.24%2.96B | -6.16%731M | 3.06%774M | 2.19%745M | 2.32%706M | -23.82%2.95B | -43.43%779M | -6.71%751M |
-Reversal of impairment losses recognized in profit and loss | ---- | ---- | ---91M | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
-Disposal profit | -340.27%-656M | -49,900.00%-2.99B | -381.72%-448M | -1,633.33%-52M | -224.36%-253M | ---149M | 150.00%6M | -205.68%-93M | -105.88%-3M | -388.89%-78M |
-Pension and employee benefit expenses | ---- | --65M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Other non-cash items | 129.36%170M | -126.11%-352M | 139.65%542M | 22.13%-535M | -1.91%308M | 50.04%-579M | 716.97%1.35B | -402.57%-1.37B | -67.56%-687M | -52.71%314M |
Changes in working capital | 26.12%2.36B | 105.50%121M | 94.67%-74M | -85.08%519M | 73.76%-264M | 157.37%1.87B | -268.68%-2.2B | -336.48%-1.39B | 487.50%3.48B | -48.60%-1.01B |
-Change in receivables | -2.65%1.91B | 283.40%2.43B | 28.08%-443M | -81.25%618M | 46.13%-1.7B | 296.79%1.96B | -647.52%-1.33B | -116.13%-616M | 430.92%3.3B | -3,353.61%-3.16B |
-Change in inventory | -127.42%-190M | -99.49%5M | 252.43%2.32B | -0.86%694M | -109.07%-42M | 150.58%693M | 174.03%972M | 10.06%-1.52B | -44.04%700M | 165.67%463M |
-Change in payables | 110.81%103M | -38.84%-1.87B | -249.57%-1.58B | -51.90%-1.24B | -15.16%1.96B | 35.87%-953M | -228.60%-1.35B | 144.08%1.06B | -219.61%-815M | 306.51%2.31B |
-Provision for loans, leases and other losses | 219.05%536M | 11.62%-441M | -18.77%-367M | 49.83%445M | 22.67%-481M | -71.57%168M | 13.22%-499M | -530.61%-309M | -49.83%297M | 2.35%-622M |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | 36.19%-67M | 26.80%-71M | -55.69%-383M | 3.33%-87M | -28.77%-94M | -144.19%-105M | -142.50%-97M | -56.69%-246M | -100.00%-90M | -97.30%-73M |
Interest received (cash flow from operating activities) | 194.44%106M | -27.46%103M | 12.43%398M | 1.37%74M | 16.80%146M | -5.26%36M | 20.34%142M | 10.28%354M | 23.73%73M | 9.65%125M |
Tax refund paid | 22.55%-158M | 15.01%-334M | 27.93%-787M | 68.23%-88M | 20.93%-102M | -39.73%-204M | 27.22%-393M | -20.53%-1.09B | -154.13%-277M | 32.81%-129M |
Other operating cash inflow (outflow) | 92.90%-64M | -300.00%-4M | -1,055.88%-975M | -333.33%-21M | -610.00%-51M | -1,770.37%-902M | -103.45%-1M | -70.86%102M | -92.91%9M | -91.38%10M |
Operating cash flow | 250.17%2.05B | 156.71%562M | 221.73%958M | -78.62%547M | 50.64%818M | 115.21%584M | -1,882.00%-991M | -122.46%-787M | 56.32%2.56B | -30.47%543M |
Investing cash flow | ||||||||||
Net PPE purchase and sale | 189.71%591M | -98.11%-733M | 10.40%-1.46B | 18.01%-255M | -69.04%-1.04B | 166.89%204M | 7.73%-370M | 55.50%-1.63B | 80.38%-311M | 43.39%-617M |
Net investment product transactions | 3,182.35%1.12B | 14,213.79%4.09B | 1,469.57%361M | 750.00%17M | 505.36%339M | 780.00%34M | 3.33%-29M | -93.29%23M | -99.45%2M | 300.00%56M |
Net changes in other investments | 154.85%113M | -423.08%-168M | 75.85%-106M | 78.18%-108M | 173.68%156M | -862.96%-206M | 285.71%52M | -242.97%-439M | -3,907.69%-495M | 216.33%57M |
Investing cash flow | 5,587.50%1.82B | 1,019.88%3.19B | 41.02%-1.21B | 56.97%-346M | -8.73%-548M | 111.31%32M | 24.40%-347M | 40.70%-2.05B | 33.55%-804M | 55.20%-504M |
Financing cash flow | ||||||||||
Net issuance payments of debt | -3.28%-2.04B | -143.84%-409M | -3,756.31%-3.77B | -88.48%-1.49B | -464.20%-1.23B | -517.51%-1.98B | 1,051.85%933M | 194.50%103M | -1,212.68%-790M | 218.87%338M |
Increase or decrease of lease financing | -16.92%-152M | -47.01%-172M | -183.45%-489M | -79.31%-156M | -21.13%-86M | -115.83%-130M | -51.95%-117M | 183.59%586M | 38.30%-87M | 58.24%-71M |
Cash dividends paid | --0 | 22.02%-131M | -4.18%-299M | --0 | 24.28%-131M | --0 | -47.37%-168M | 37.47%-287M | --0 | 24.78%-173M |
Net other fund-raising expenses | 99.42%-1M | 42.40%-144M | -2.08%-441M | 1.02%-390M | --372M | ---173M | -557.89%-250M | -644.83%-432M | ---394M | --0 |
Financing cash flow | 3.72%-2.2B | -315.08%-856M | -16,550.00%-5B | -40.80%-1.65B | -18,212.50%-1.47B | -276.22%-2.28B | 368.92%398M | 97.74%-30M | -1,570.00%-1.17B | 97.27%-8M |
Net cash flow | ||||||||||
Beginning cash position | -4.93%14.43B | -29.65%11.18B | -13.93%15.89B | -19.36%12.81B | -11.98%13.89B | -16.61%15.17B | -13.93%15.89B | -2.00%18.46B | -10.18%15.88B | -13.84%15.78B |
Current changes in cash | 200.12%1.67B | 408.30%2.9B | -82.98%-5.25B | -346.59%-1.45B | -3,954.84%-1.2B | 41.07%-1.67B | -43.07%-940M | -123.98%-2.87B | 64.15%586M | 104.87%31M |
Effect of exchange rate changes | 27.65%494M | 53.71%352M | 80.47%536M | 68.16%-185M | 64.06%105M | -6.52%387M | -42.75%229M | -67.18%297M | -238.66%-581M | 2,233.33%64M |
Cash adjustments other than cash changes | --0 | --1M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
End cash Position | 19.40%16.59B | -4.93%14.43B | -29.65%11.18B | -29.65%11.18B | -19.36%12.81B | -11.98%13.89B | -16.61%15.17B | -13.93%15.89B | -13.93%15.89B | -10.18%15.88B |
Free cash flow | 178.26%1.54B | 87.44%-171M | 60.34%-963M | -96.87%71M | -120.59%-225M | 113.32%552M | -201.77%-1.36B | -490.75%-2.43B | 1,287.96%2.27B | 66.99%-102M |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |